Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 15/20 | 0.68 |
| ▸ | KDR | P35968 | 9/20 | 0.68 |
| ▸ | JAK3 | P52333 | 9/20 | 0.68 |
| ▸ | MAPK14 | Q16539 | 9/20 | 0.68 |
| ▸ | TEK | Q02763 | 4/20 | 0.68 |
| ▸ | BRAF | P15056 | 2/20 | 0.64 |
| ▸ | ABL1 | P00519 | 3/20 | 0.47 |
| ▸ | KIT | P10721 | 1/20 | 0.46 |
| ▸ | SRC | P12931 | 1/20 | 0.46 |
| ▸ | DDR2 | Q16832 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5494016 | 0.93 | LCK (0.78) | LCKKDRJAK3MAPK14TEK | |
| SCHEMBL5489144 | 0.92 | LCK (0.67) | LCKKDRJAK3MAPK14TEK | |
| SCHEMBL5489006 | 0.92 | LCK (0.67) | LCKKDRJAK3MAPK14TEK | |
| SCHEMBL5502467 | 0.90 | LCK (0.77) | LCKKDRJAK3MAPK14TEK | |
| SCHEMBL5499129 | 0.89 | LCK (0.76) | LCKKDRJAK3MAPK14TEK | |
| SCHEMBL5494677 | 0.87 | ABL1 (0.66) | LCKKDRJAK3MAPK14TEK | |
| SCHEMBL5490661 | 0.87 | LCK (0.73) | LCKKDRJAK3MAPK14TEK | |
| SCHEMBL5501487 | 0.85 | LCK (0.63) | LCKKDRJAK3MAPK14TEK | |
| SCHEMBL5498156 | 0.85 | LCK (0.68) | LCKKDRJAK3MAPK14TEK | |
| SCHEMBL5500366 | 0.85 | LCK (0.68) | LCKKDRJAK3MAPK14TEK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1836174-B1 | ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS | AMGEN INC (US) | 2013-02-27 | — | — | EP | claimed |